Abstract
Even before the question could be studied in man, an increased incidence of cancer in organ transplant recipients was implied by the immunosurveillence hypothesis proposed by Thomas (1959) and Burnet (1965). Their predictions have been amply confirmed by observations since then, but in ways that have helped to modify the original theory. These observations have come from follow-up studies of transplant recipients, together with details of malignancies collected from around the world by Penn. The findings, briefly reviewed here, are of both clinical and scientific interest.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson JL, Bieber CP, Fowles RE, Stinson EB (1978) Idiopathic cardiomyopathy, age and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet 2:1174–1177
Bencini PL, Montagnino G, DeVecchi A, Crosti C, Tarantino A (1986) Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients. Dermatologica 172:24–30
Burnet FM (1965) Somatic mutation and chronic disease. Br Med J:338–342
Calne RY, Rolles K, Thiru S, McMaster P, Craddock GN, Aziz S, White DJG, Evans DB, Dunn DC, Henderson RG, Lewis G (1979) Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet 2:1033–1036
Cutler SJ, Young JL (1975) (eds) Third national cancer survey: incidence data. NCI Monogr 41
Doll R, Kinlen L (1970) Immunosurveillance and cancer: epidemiological evidence. Br Med J 4:420–422
Hoover R, Fraumeni JF Jr (1973) Risk of cancer in renaltransplant recipients. Lancet 2:55–57
Hoover R, Fraumeni JF Jr (1982) Personal communication quoted in Kinlen 1982. In: Cancer Surveys 1:4
Kay HE (1983) Immunosuppression and the risk of brain lymphomas. N Engl J Med 308:1099–1100
Kinlen LJ (1982) Immunosuppressive therapy and cancer. Cancer Surveys 1:565–583
Kinlen LJ (1985) Incidence of cancer in rheumatoid athritis and other disorders after immunosuppressive treatment. Am J Med 78 (Suppl 1A): 44–49
Kinlen LJ, Sheil AGR, Peto J, Doll R (1979) A collaborative U.K.-Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 2: 1461–1466
Kinlen LJ, Doll R, Peto J (1983) The incidence of tumors in human transplant recipients. Transplant Proc 15:1039–1042
Kripke ML (1981) Immunologic mechanisms in UV radiation carcinogenesis. Adv Cancer Res 34:69–106
Penn I (1979) Host origin of lymphomas in organ transplant recipients. Transplantation 27:214
Penn I (1982) The occurrence of cancer in immune deficiencies. Curr Probi Cancer 6:10
Penn I (1988) Transmission of cancer with donor organs. Transplant Proc 20:739–740
Sheil AGR, Flavel S, Disney APS, Mathew TH, Hall BM (1987) Cancer incidence in renal transplant patients treated with azathioprine or cyclosporine. Transpl Proc 19:2214–2216
Smith JL, Wilkinson AH, Hunsicker LG, Tobacman J, Kapelanski DP, Johnson M, Wright FH, Behrendt DM, Corry RJ (1989) Increased frequency of posttrans-plant lymphomas in patients treated with cyclosporin, azathioprine and prednisone. Transplant Proc 21:3199–3200
Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW, Hardesty RL, Atchison RW, Jaffe R (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583–587
Thomas L (1959) Discussion. In: Lawrence HS (ed) Cellular and humoral aspects of the hypersensitive states. Hoeber-Harfer, New York, pp 529–532
Walder BK, Robertson MR, Jeremy D (1971) Skin cancer and immunosuppression. Lancet 2:1282–1283
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kinlen, L.J. (1991). Malignancies in Man After Organ Transplantation. In: Schmähl, D., Penn, I. (eds) Cancer in Organ Transplant Recipients. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75991-8_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-75991-8_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53020-6
Online ISBN: 978-3-642-75991-8
eBook Packages: Springer Book Archive